I agree that this site is using cookies. You can find further informations here.
X
Iams, W.T.
142  results:
Search for persons X
?
1

Phase I study of peposertib and avelumab with or without pa..:

Perez, B. ; Aljumaily, R. ; Marron, T.U....
ESMO Open.  9 (2024)  2 - p. 102217 , 2024
Link: https://doi.org/10.1016/..
 
?
2

RWD121 Moment Registry (MET NON SMALL CELL CANCER REGISTRY)..:

Thomas, M. ; Christopoulos, P. ; Iams, W.T....
Value in Health.  26 (2023)  12 - p. S527 , 2023
Link: https://doi.org/10.1016/..
 
?
3

OA21.06 ctDNA Dynamics, Prognostic Markers and Resistance M..:

Le, X. ; Garassino, M.C. ; Ahn, M.-J....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S94-S95 , 2023
Link: https://doi.org/10.1016/..
 
?
4

PP01.56 Peripheral T-Cell Receptor Repertoire Dynamics in P..:

Balbach, M.L. ; Axelrod, M.L. ; Balko, J....
Journal of Thoracic Oncology.  18 (2023)  3 - p. e34 , 2023
Link: https://doi.org/10.1016/..
 
?
5

EP08.02-126 The MOMENT Disease Registry of Patients with Ad..:

Christopoulos, P. ; Iams, W.T. ; Oksen, D....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S463 , 2022
Link: https://doi.org/10.1016/..
 
?
6

A Phase 1 Study of TAK-676, a Novel STING Agonist, Plus Pem..:

Gerber, N.K. ; Chmura, S.J. ; Luke, J.J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e40 , 2022
Link: https://doi.org/10.1016/..
 
?
7

METex14 ctDNA Dynamics & Resistance Mechanisms Detected in ..:

Paik, P. ; O'Hara, R. ; Veillon, R....
International Journal of Radiation Oncology*Biology*Physics.  112 (2022)  2 - p. e13-e14 , 2022
Link: https://doi.org/10.1016/..
 
?
8

183P COMMANDER-001: Initial safety data from a phase I/II d..:

Moser, J. ; Pelster, M. ; Jimeno, A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100295 , 2022
Link: https://doi.org/10.1016/..
 
?
9

OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy ..:

Li, B.T. ; Falchook, G.S. ; Durm, G.A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S10-S11 , 2022
Link: https://doi.org/10.1016/..
 
?
10

191P Preliminary biomarker and safety results of SQZ-PBMC-H..:

Jimeno, A. ; Miselis, N.R. ; Park, J.C....
Immuno-Oncology and Technology.  16 (2022)  - p. 100303 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Radiation Oncology Education for Medical Oncology Fellowshi..:

Paudel, N. ; Pro, B. ; Boddy, C....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e395 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Prognostic Implications of KRAS Mutation Status and KRAS Mu..:

Iams, W.T. ; Hames, M.L. ; Chen, H....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  5 - p. S42 , 2014
Link: https://doi.org/10.1016/..
 
?
13

11MO Final data from a phase II study (TACTI-002) of eftila..:

Majem, M. ; Forster, M.D. ; Krebs, M.G....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S43-S44 , 2023
Link: https://doi.org/10.1016/..
 
?
14

EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alph..:

Forster, M. ; Krebs, M. ; Majem, M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S395 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Hepatitis C Virus Antibody Screening in a Cohort of Pregnan..:

Prasad, Mona ; Saade, George R. ; Sandoval, Grecio...
Obstetrics & Gynecology.  135 (2020)  4 - p. 778-788 , 2020
Link: https://doi.org/10.1097/..
 
1-15